Skip to content
Mahaz News
US
World
Business
Entertainment
Technology
Sports
Health
Search for:
Home
Johnson & Johnson
Business
What to consider ‘Peak 65’
Business
J&J, Merck and Bristol Myers CEOs, below fireplace on Capitol Hill, search to show up warmth on drug-market middlemen
Business
Johnson & Johnson’s earnings beat estimates with enhance from medical-technology gross sales
Business
Kenvue’s inventory rises after favorable court docket ruling in Tylenol litigation
Business
Why a derailed $11 trillion company bond market seems ripe for a comeback as U.S. inflation slows
Business
The timing could also be good for this dividend-stock fund if the market is getting near a high
Business
U.S. shares largely decrease as Netflix, Tesla weigh on Nasdaq; IBM, J&J enhance Dow
Business
Johnson & Johnson swings to loss because it books multibillion-dollar cost to settle talc claims
Business
J&J’s proposal to settle talc lawsuits for $8.9 billion sends replenish essentially the most in additional than a yr
Business
Johnson & Johnson units apart $8.9 billion to settle talc claims; top off 3%